XML 33 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investments in ADVENTRX Pharmaceuticals (Details) (USD $)
Dec. 31, 2014
Jun. 06, 2012
Oct. 11, 2011
Apr. 08, 2011
SynthRx, Inc. [Member]        
Schedule of Equity Method Investment [Line Items]        
Equity investment, ownership percentage (in hundredths)       19.10%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_SynthrxIncMember
ADVENTRX Pharmaceuticals [Member]        
Schedule of Equity Method Investment [Line Items]        
Common stock received in acquiring company upon acquisition of equity method investee (in shares)       126,000cytr_CommonStockReceivedInAcquiringCompanyUponAcquisitionOfEquityMethodInvestee
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_AdventrxPharmaceuticalsMember
Proceeds from sale of common stock in acquiring entity   $ 17,900cytr_ProceedsFromSaleOfCommonStockInAcquiringEntity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_AdventrxPharmaceuticalsMember
$ 112,200cytr_ProceedsFromSaleOfCommonStockInAcquiringEntity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_AdventrxPharmaceuticalsMember
 
Additional shares of common stock held in an escrow potentially issuable (in shares)   38,196cytr_AdditionalSharesOfCommonStockHeldInEscrowPotentiallyIssuable
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_AdventrxPharmaceuticalsMember
   
Additional shares of common stock potentially issuable from development milestones, maximum (in shares) 2,900,000cytr_AdditionalSharesOfCommonStockPotentiallyIssuableFromDevelopmentMilestonesMaximum
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cytr_AdventrxPharmaceuticalsMember